ABSTRACT Juniperus phoenicea ssp. Turbinata L. ( J. phoenicea ssp. Turbinata) has long been used in traditional medicine to treat a variety of ailments. This study aimed to investigate the pharmacological potential and to characterize the phytochemical composition of the hydroethanolic leaf (JPEF) and fruit (JPEG) extracts. Liquid Chromatography Tandem Mass Spectrometry (LC–MS/MS) analysis revealed that both JPEF and JPEG contained high levels of phenolic compounds, with ferulic acid identified as the dominant constituent. The biological evaluation began with acute toxicity tests in rodents, which indicated that JPEF and JPEG extracts were well tolerated at the doses administered, with no significant adverse effects observed. The extracts exhibited strong anti‐inflammatory activity (94.23% for JPEF; 83.24% for JPEG), comparable to that of diclofenac (97.02%), as well as a notable analgesic effect (75% and 70.62%), compared to tramadol (87.01%). Significant antioxidant activity was observed (DPPH IC 50 : 70.2 and 90.76 μg/mL), accompanied by antimicrobial activity (bacterial inhibition zones: 11.44–20.36 mm; fungal: 13.59–20.38 mm). Molecular docking revealed a stable interaction between the compounds and several enzymatic targets. These results confirm the potential of J. phoenicea ssp. turbinata as a promising source of therapeutic agents.
Presently, there is no vaccine for hepatitis C virus (HCV) and available drugs present with adverse effects that have prompted the search for newer and safer alternatives. The present study evaluated the anti-HCV potential of selected bioactive compounds from Jatropha tanjorensis and Solanum nigrum against HCV non-structural (NS2-3) protein. The selected bioactive compounds (3-methoxy-4-methylaniline, 2,2'-Azoxybis[3-methylpyridine], isopropyl thiophosphondiamide, and squalene) were screened for compliance with Lipinski's role five (LRF) and toxicity using the MCULE tool. Furthermore, the ligands were docked against the NS2-3 (2hd0) protein with ledipasvir, and a co-crystal as controls using the Autodock Vina tool. Docking scores were generated using the London dG scoring function. Following docking, a 200 nanosecond (nsec) simulation run was performed using the Schrodinger Desmond module. In addition, density functional theory (DFT) was utilised to evaluate their reactivities. The selected compounds were not toxic and obeyed the LRF. Molecular docking scores for ledipasvir and the co-crystal were - 8.8 and - 6.3 kcal/mol, respectively while of the ligands ranged from - 3.5 to -7.3 kcal/mol, implying favourable bindings. The amino acid residues involved in the binding were those within the active site of the target protein. RMSD values indicated that isopropyl thiophosphondiamide was the most stable ligand. PSA, MolSA and SASA values suggest stability and availability for water contact. DFT calculations indicate that the compounds were moderately stable and highly reactive, with energy gaps that ranged from 0.5810 to 1.0621 eV. The favourable pharmacokinetics and docking outputs observed in this study needs to be further validated using in vitro and in vivo studies.
hepatitis C virusanti-HCV activityphytochemicalsJatropha tanjorensis
Erythema annulare centrifugum (EAC) is a rare reactive dermatosis that can be difficult to manage in persistent cases.A 54-year-old woman presented with pruritic, annular, and polycyclic plaques that subsequently extended to the neck, trunk, upper back, hands, lower legs, and feet.A skin biopsy supported the diagnosis of superficial EAC on clinicopathologic correlation.After limited improvement with topical therapies and oral prednisolone, she received four weekly doses of empiric oral fluconazole 150 mg without adverse effects.The eruption improved, and approximately five months after treatment discontinuation, she remained clear apart from residual post-inflammatory hyperpigmentation.The temporal association suggests a possible treatment response; however, the absence of pretreatment mycologic testing and the possibility of spontaneous remission limit causal interpretation.
Journal of Pubnursing Sciences · مجلد 4 (03) · 113-122
Background: Schizophrenia severely impacts quality of life (QoL), and medication adherence is crucial for managing symptoms and preventing relapse. However, adherence remains a significant challenge in resource-limited settings. Aims: This study aimed to evaluate the relationship between medication adherence and quality of life among adult patients with schizophrenia in North-Western Nigeria. Methods: A descriptive cross-sectional study was conducted involving 865 patients across seven states in North-Western Nigeria. Participants were selected using a multistage sampling technique. Adherence and QoL were assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8) and the WHOQOL-BREF, respectively. Data analysis included descriptive statistics, chi-square tests, and binary logistic regression (p < 0.05). Results: Findings revealed that 44.9% of participants had good adherence, 32.8% had moderate adherence, and 22.3% were poorly or non-adherent. Significant predictors of non-adherence included high medication costs (AOR = 4.25), adverse side effects (AOR = 3.14), poor drug accessibility (AOR = 2.94), polypharmacy (AOR = 2.71), and low educational attainment (AOR = 2.08). Good medication adherence was significantly associated with improved QoL across the physical, psychological, social, and environmental domains (p < 0.001). Conclusion: Medication adherence among these patients is suboptimal, primarily due to socio-economic and clinical barriers. Since adherence strongly predicts improved QoL, interventions should focus on affordable medication access, side-effect management, and psychoeducation.
medication adherencequality of lifeschizophreniaantipsychotic adverse effects
Frontiers in Pharmacology · مجلد 17 · 1826774-1826774
Introduction: Myelotoxicity is a common adverse effect of vincristine and other chemotherapeutic drugs. Hesperetin is a bioactive flavanone with anti-inflammatory activity. This study was planned to examine the hesperetin protecting effect against vincristine induced myelosuppression and splenic inflammation in mice and test whether this effect is mediated through the suppression of Toll-like receptor 4 (TLR4)/myeloid differentiation primary response-88 (MYD88)/nuclear factor-kappa B (NF-κB) signaling pathways. Methods: Bioinformatics tools were used to establish the rationale of the study and molecular docking defined the potential binding of hesperetin to TLR4. Mice were allocated into different experimental groups: Group 1: was the saline mice, Group 2; mice were injected with vincristine (0.1 mg/kg, i. p) for 5 days per week, Group 3; mice received vincristine (as in Group 2) plus hesperetin (100 mg/kg, p. o.) and Group 4; mice received hesperetin (100 mg/kg, p. o.) only; the experiment continued for 2 weeks. Results: 9/L in the saline group, p less than 0.05) and bone marrow hypocellularity (dropped to ∼30-40% compared to 95%-100% in the saline group). The spleens showed white pulp lymphoid depletion, red pulp mild hypocellularity, greater immunostaining for MYD88, and greater content for TLR4, NF-κB, MYD88, TNF-α and IL-1β proteins. Results of molecular docking showed that hesperetin is an interesting complementarity with the TLR4/MD2 interface which was a good rationale for the experimental validation. The mouse experiment showed that hesperetin prevented the decrease hematological parameters, enhanced the bone marrow cellularity to 80%-90%, and the splenic architecture. Hesperetin further inhibited the increases in the target proteins (TLR4, NF-κB, MYD88, TNF-α and IL-1β) significantly. Discussion: The present data documents the novel role of hesperetin in mitigating myelotoxicity of vincristine through modulation of TLR4/MYD88/NF-κB signaling and a direct binding to TLR4 was proposed by molecular docking. This highlights possible usefulness of this combination after adequate clinical studies.
The safety profile for bio-derived phenols post-oxidation and their related antioxidant/redox potential remain largely under-explored. Oxidation by fungi, in terms of environmental impacts via fungal oxidation by enzymes, remains an attractive strategy under milder conditions, since it is one route by which many naturally occurring lignocellulosic phenols are modified; thus, an immediate need still exists for characterizing the effects that these modified phenolic compounds may have. METHODOLOGY: We examined four different biomass-derived phenolics-vanillin, ferulic acid, syringaldehyde and guaiacol-that were oxidized with fungal laccase and characterized their effects on normal human lung fibroblasts and levels of cellular oxidative stress. Laccase activity was evaluated via the ABTS method and through simple observation and UV-Vis spectroscopic scanning of the phenolics in question, and compared with the untreated version of each phenolic. In addition to assessing the cytotoxic effect and oxidative stress generated by the phenols alone, an ELISA-based measurement assay was used to investigate the relative abundance of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and reduced glutathione (GSH) in the human normal lung fibroblast cell line under varying treatment regimes, complemented by phase-contrast microscopy. Scores integrating the biomarkers were analyzed via clustering, PCA, radar and Pearson correlation analyses, to discern distinct trends in antioxidant potential after laccase conversion. OBSERVATIONS: Each of the four tested phenolics demonstrated the presence of laccase activity, leading to substantial differences in visible appearance compared with the control and characteristic absorbance shifts at differing wavelengths from the original molecule. Cell viability dropped dramatically as phenol concentration was increased and the untreated phenolics resulted in diminished confluence and induced greater levels of oxidative damage, from guaiacol and syringaldehyde. Laccase treatment resulted in higher MTT reduction activity and improved cellular morphology compared with the corresponding untreated phenolic compounds. Untreated phenols induced the highest levels of MDA, while decreasing SOD, CAT, GPx and GSH levels. Post-oxidation with laccase, there were lower amounts of lipid peroxidation, along with improved levels of antioxidant activity compared with the control phenol. Multi-technique analyses show clear distinctness between the untreated and laccase-converted phenolic groups. Clustering with multivariate techniques separated all cell groups in line with control samples, grouping the laccase-converted treatments towards the middle and displaying an inverse relationship between MDA and the antioxidant markers. CONCLUSIONS: Laccase conversion markedly decreases the adverse effects that bio-derived phenols have on normal cell viability and induces fewer detrimental effects on the cellular redox balance. This is a critical discovery in terms of finding greener methods by which to upgrade bio-derived substances as we research these lignocellulosic phenols. By employing ELISA-based measurements along with multiple analysis techniques, we present a suitable paradigm for studying biological effects in all bio-based goods intended for pharmaceuticals, packaging materials, nutraceuticals or a host of different applications.
International Journal of Community Medicine and Public Health
Laser-based aesthetic procedures rely heavily on the interaction between laser energy and the skin’s vascular system. The effectiveness of these treatments often depends on the ability to precisely target and modulate blood vessels without damaging surrounding tissue. Key to this process is selective photothermolysis, where laser wavelengths are absorbed by hemoglobin, leading to controlled thermal injury and vessel coagulation. The biological response that follows includes inflammatory signaling, thrombosis, and subsequent vascular remodeling, all of which contribute to clinical improvements in conditions like telangiectasia, port-wine stains, and facial erythema. The extent of vascular response is shaped by numerous variables such as vessel size, blood flow rate, depth, and the optical properties of the skin. Laser parameters including wavelength, pulse duration, and fluence must be carefully matched to these vessel characteristics to ensure effective treatment. In patients with darker skin tones, melanin competes with hemoglobin for light absorption, raising the risk of pigmentation issues. Protective measures like epidermal cooling and longer wavelengths help reduce adverse effects while maintaining efficacy. Treatment outcomes are also influenced by anatomical location, pre-existing vascular conditions, and patient-specific healing responses. Technological advancements, including dynamic cooling, pulse stacking, and multispectral lasers, have improved precision and safety. Monitoring vascular behavior during treatment allows for real-time adjustments, making procedures more adaptable to individual needs. Together, a deeper understanding of vascular mechanisms and improved device control continues to expand the potential of laser-based aesthetics, offering more consistent and personalized results across a wide range of skin types and vascular presentations.
The Journal of Clinical Pharmacology · مجلد 66 (1) · e70139-e70139
Valproic acid (VPA) is highly protein-bound, thereby impacting its free fraction and clearance in hypoalbuminemia. There is limited data on VPA use in such patients. Thus, this study evaluates the impact of adjusted VPA concentration (aVPAc) in predicting effectiveness and adverse effects compared to total VPA (tVPA) levels in hypoalbuminemic patients. A retrospective cohort study involved adult patients with seizures or epilepsy between January 1, 2016, and December 31, 2022. The levels of tVPA and aVPA (adjusted for albumin) were compared using receiver operating characteristic curves, and AUC differences were assessed using the DeLong method. Safety endpoints included hepatotoxicity, hyperammonemia, hyponatremia, and thrombocytopenia, while effectiveness endpoints were seizure occurrence, status epilepticus, and the use of additional antiepileptic medications during hospitalization. Of the 1621 screened patients, 71 with hypoalbuminemia received VPA. An aVPAc threshold of 154.19 mg/dL demonstrated higher sensitivity (86%) but lower specificity (47%) for predicting hepatotoxicity compared to a tVPA threshold of 67.53 mg/dL (sensitivity: 71%, specificity: 72%). Although aVPAc yielded a comparable negative predictive value (96% vs 95%), tVPA showed superior positive predictive value (25% vs 18%) and a higher Youden index (0.43 vs 0.33), indicating better overall discriminatory performance; however, these findings did not achieve statistical significance. In contrast, an aVPAc threshold of 188 mg/dL showed a sensitivity of 100% and a specificity of 82% for predicting hyperammonemia, which is superior to the tVPA threshold of 74.32 mg/dL that has a sensitivity of 40% and a specificity of 88%. The aVPAc also achieved a higher Youden index of 0.82 compared to 0.28 for tVPA. Adjusted VPA concentrations showed greater sensitivity than tVPA in predicting hepatotoxicity and hyperammonemia, suggesting potential utility for ruling out these adverse effects in hypoalbuminemic patients. Further research with a larger sample size is needed to validate these findings.
ABSTRACT The growing environmental concerns associated with petrochemical‐based plastics, including their persistence, contribution to climate change, and adverse effects on ecosystems and human health, have accelerated the search for sustainable alternatives. Starch‐based bioplastics have emerged as a promising solution due to their biodegradability, renewability, and compatibility with existing food packaging technologies. This review comprehensively examines production mechanisms of starch‐based bioplastics, focusing on their formulation, structural modifications, and industrial applications. The role of plasticizers in improving flexibility and reducing brittleness is discussed. Their natural decomposition into environmentally benign byproducts supports a circular economy and aligns with global sustainability goals. However, the downside of using bioplastic is that the raw material used for its fabrication is also used for sustenance, and so a trade‐off between growing feedstock crops and food production is inevitable. The higher manufacturing costs of bioplastics as compared to conventional plastics are also a limiting factor. Hence, bioplastics do not completely serve as a long‐term panacea for problems associated with plastic pollution. This review therefore attempts to (i) enumerate the benefits of starch in food packaging, (ii) delineate the physical and chemical treatments that enhance hydrophobicity, mechanical strength, and thermal stability, (iii) suggest the proper disposal procedures to ward off health issues and to conserve the environment, and (iv) advocate the implementation of stringent recycling measures and emphasize on the policies and legislation for green transition. Future research should focus on optimizing polymer blends, reinforcing compatibility with synthetic and natural polymers, and advancing manufacturing techniques to enable widespread adoption in food packaging applications.
INTRODUCTION: According to the World Health Organization (WHO), herbal medicines contribute to skills and practices used in cultures worldwide to manage physical and mental disorders. In Saudi Arabia during COVID-19, herbal medicine use increased due to the perceived safety of herbal medications, especially among pregnant women and individuals with health conditions. Objectives: The objective of this study was to determine the responsibilities and attitudes of community pharmacists toward herbal medicine use. METHODS: In this cross-sectional study, data were collected to obtain information on demographics, attitudes towards herbal medicines, safety knowledge, and the factors influencing communication. The selected sample included community pharmacists in Saudi Arabia. Results: Among the 387 pharmacist participants, the majority were male (n=313, 80.9%) and most acquired herbal medicine knowledge by Internet research (n=146, 37.7%) and from company information (n=139, 35.9%). There was a significant association between the perceived benefit of herbal medication by pharmacists with the non-agreement of using herbal medication from unknown sources (p < 0.05), and they observed that consumers are generally unaware of their possible adverse effects. The majority of participants claimed to be effectively and frequently communicating with their patients. Conclusion: Most participating pharmacists were male and primarily acquired herbal medicine knowledge through online resources and company information, with many recognizing both the benefits and potential risks of herbal products while actively communicating with patients. To improve public awareness and ensure safe herbal medication use, community pharmacists should receive further training and advocate for expanded research in this area.
Journal of Infection and Public Health · مجلد 18 (10) · 102873-102873
BACKGROUND: While COVID-19 has transitioned from a pandemic to an endemic state, the management of its persistent complications continues to present substantial clinical challenges. Tocilizumab, an interleukin-6 receptor antagonist endorsed by the World Health Organization (WHO) for severe COVID-19 management, remains a critical therapeutic intervention. This systematic evaluation provides a comprehensive assessment of tocilizumab's safety and efficacy profile to inform clinical decision-making. METHODS: The study involved exhaustive search across multiple databases (PubMed, SCOPUS, WoS, BIOSIS) utilizing MeSH terms and Boolean operators to identify relevant studies. Methodological worthiness was rigorously evaluated utilizing the Risk of Bias 2 (RoB 2) tool. The statistical analysis of the findings incorporated one-way ANOVA, Mann-Whitney U tests, and Pearson's correlation coefficient (r) with 95 % confidence intervals to quantify adverse effects and therapeutic outcomes. RESULTS: The analysis of nine studies encompassing diverse demographic populations (ages ≥2 years, both sexes) established a clear safety profile for tocilizumab. The treatment demonstrated a statistically important association (P < 0.05) with mild adverse effects (nausea, diarrhea, headache, fatigue; r = 0.62, 95 % CI = 0.59-0.71) and moderate adverse effects (tremors, urinary difficulties, mood changes; r = 0.54, 95 % CI = 0.47-0.60). More concerning were the severe adverse effects, including hepatobiliary dysfunction and hypersensitivity reactions (r = 0.36, 95 % CI = 0.32-0.41), with rare but critical instances of acute liver failure (r = 0.18, 95 % CI = 0.15-0.22). Notably, despite this safety profile, tocilizumab exhibited significant therapeutic efficacy (P < 0.01) in ameliorating COVID-19 symptoms, particularly in cases complicated by cytokine storm syndrome. CONCLUSION: This study confirms tocilizumab's position as a valuable therapeutic agent for COVID-19 complications while highlighting the necessity for judicious patient selection and vigilant monitoring due to its potential for significant adverse effects. The findings underscore the importance of pre-treatment screening, adherence to contraindications, and ongoing pharmacovigilance to optimize risk-benefit ratios.
Lassa fever hemorrhagic virus (LFHV) outbreaks in Nigeria continue to increase. With the possibility of a potentially deadly pandemic and the absence of a vaccine, an effective candidate drug that presents with no adverse effects and better clinical outcomes is urgently needed; hence, the aim of the study. Retrieved ligands: 5-(Methylene) evodiamine, N-(2-Fluorobenzoyl) evodiamine, N-[[2-(3-chlorophenyl)-5-(trifluoromethyl) pyrazol-3-yl]methyl]-2-(1-methyl-2,3-dihydroindol-5-yl) propanamide (NCTPMMDP), lauric acid, and sofosbuvir, and the target protein, 3MX5, were prepared and utilised for docking, molecular dynamics simulation, ADMET profiling, and DFT using standard protocols. The docking score for lauric acid was the lowest, with a value of - 6.1, followed by the standard drug and co-crystal control drug with scores of - 9.1 and - 8.9 kcal/mol, respectively. On the other hand, the scores of the other ligands ranged from - 9.5 to - 12.3 kcal/mol. Molecular simulations revealed fluctuations in the RMSD and RMSF values; however, overall, the formed complexes were stable during most of the docking simulation runs. Principal component analysis (PCA) analysis showed that all the ligands, apart from lauric acid, showed better conformational changes within the backbone of the protein. ADMET profiling showed that the ligands were better oral drug candidates than sofosbuvir, as revealed by their better absorption values and absolute compliance with the Lipinski rule of five. The DFT result showed that, apart from lauric acid, all the test ligands possess small energy gaps indicative of high reactivity. Put together, these findings indicate that the test ligands possess anti-LHFV potential that merits further in vivo and in vitro evaluations.
nucleocapsid proteinantiviral drug discoverysmall-molecule ligandsmolecular docking
Advanced Health Science and Technology Journal · مجلد 1 (2) · 86-91
Abstract Background: Chronic rhinosinusitis (CRS) is a persistent inflammatory disorder of the paranasal sinuses, significantly impairing quality of life (QoL). While corticosteroids are central to CRS management, evidence from Saudi Arabia remains limited. Objectives: This study aimed to (1) evaluate the improvement in CRS symptoms following corticosteroid therapy, (2) compare the effectiveness of intranasal versus systemic corticosteroids, (3) analyze side effects, and (4) assess the impact of therapy on QoL among Saudi patients. Methodology: A cross-sectional descriptive study was conducted among Saudi adults with physician-diagnosed CRS and prior corticosteroid use. Data were collected via an online questionnaire incorporating the validated Sino-Nasal Outcome Test-22. Descriptive and inferential statistics were performed using SPSS. Results: Of 201 participants, 78.6% had a CRS diagnosis and 70.6% used intranasal corticosteroids. Most patients (88.6%) reported moderate-to-complete improvement in symptoms, with intranasal sprays demonstrating significantly greater effectiveness compared to oral corticosteroids ( P < 0.001). Adverse effects were rare, with 95.5% reporting none; headaches (2.5%) and nausea (1.0%) were the most common. Quality-of-life scores improved, although persistent issues included nasal congestion, loss of smell, and daily irritation. Conclusion: Corticosteroid therapy–particularly intranasal sprays–is highly effective and well-tolerated in Saudi patients with CRS. These findings align with global evidence and highlight the need for patient education and improved adherence to optimize outcomes within the Saudi healthcare context.
International Journal of Pharmaceutics X · مجلد 7 · 100232-100232
Diabetes mellitus (DM) is the most prevalent cause of diabetic retinopathy (DRP). DRP has been recognized for a long time as a microvascular disease. Many drugs were used to treat DRP, including vildagliptin (VLD). In addition to its hypoglycemic effect, VLD minimizes ocular inflammation and improves retinal blood flow for individuals with type 2 diabetes mellitus. Nevertheless, VLD can cause upper respiratory tract infections, diarrhea, nausea, hypoglycemia, and poor tolerability when taken orally regularly due to its high water solubility and permeability. Effective ocular administration of VLD is achieved using solid lipid nanoparticles (SLNPs), which improve corneal absorption, prolonged retention, and extended drug release. Ocuserts (OCUs) are sterile, long-acting ocular dosage forms that diminish the need for frequent dosing while improving residence time and stability. Therefore, this study intends to develop VLD solid lipid nanoparticle OCUs (VLD-SLNPs-OCUs) to circumvent the issues commonly associated with VLD. SLNPs were prepared using the double-emulsion/melt dispersion technique. The optimal formula has been implemented in OCUs. Optimization and development of VLD-SLNPs-OCUs were performed using a Box-Behnken Design (BBD). VLD-SLNPs-OCUs loading efficiency was 95.28 ± 2.87%, and differential scanning calorimetry data (DSC) showed the full transformation of VLD to an amorphous state and the excellent distribution in the prepared OCUs matrices. The in vivo release of VLD from the optimized OCUs after 24 h was 35.12 ± 2.47%, consistent with in vitro drug release data of 36.89 ± 3.11. The optimized OCUs are safe to use in the eye, as shown by the ocular irritation test. VLD-SLNPs-OCUs provide extended VLD release, an advantageous alternative to conventional oral dose forms, resulting in fewer systemic adverse effects and less variation in plasma drug levels. VLD-SLNPs-OCUs might benefit retinal microvascular blood flow beyond blood glucose control and may be considered a promising approach to treating diabetic retinopathy.
vildagliptinsolid lipid nanoparticlesOcusertocular drug delivery
Oral squamous cell carcinoma (OSCC) is a highly malignant and invasive tumor with significant mortality and morbidity. Current treatment modalities such as surgery, radiotherapy, and chemotherapy encounter significant limitations, such as poor targeting, systemic toxicity, and drug resistance. There is an urgent need for novel therapeutic strategies that offer targeted delivery, enhanced efficacy, and reduced side effects. The advent of lipid-based nanoparticles (LNPs) offers a promising tool for OSCC therapy, potentially overcoming the limitations of current therapeutic approaches. LNPs are composed of biodegradable and biocompatible lipids, which minimize the risk of toxicity and adverse effects. LNPs can encapsulate hydrophobic drugs, improving their solubility and stability in the biological environment, thereby enhancing their bioavailability. LNPs demonstrate significantly higher ability to encapsulate lipophilic drugs than other nanoparticle types. LNPs offer excellent storage stability, minimal drug leakage, and controlled drug release, making them highly effective nanoplatforms for the delivery of chemotherapeutic agents. Additionally, LNPs can be modified by complexing them with specific target ligands on their surface. This surface modification allows the active targeting of LNPs to the tumors in addition to the passive targeting mechanism. Furthermore, the PEGylation of LNPs improves their hydrophilicity and enhances their biological half-life by reducing clearance by the reticuloendothelial system. This review aims to discuss current treatment approaches and their limitations, as well as recent advancements in LNPs for better management of OSCC.
oral squamous cell carcinomalipid nanoparticlestargeted drug deliverychemotherapy